The treatability of Down Syndrome is gaining evidence and support, but remains the "holy grail" for parents and doctors. A rare gathering of expert scientists will plan the next stage in human treatments for Down syndrome. The wider context of the impact on people with Alzheimer's with be discussed.
Rarely are such people all the same room together, but September 17th sees the meeting of truly great minds in Cambridge at the Welcome Genome Campus. ...
Satisfied Users & 
Approved Press Releases
